Moonbase
← Back to Awards
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH

Clinical Pharmacology Quality Assurance (CPQA)

Morse, Gene (Contact)·STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY·2025–2026·COMPLETED
Donate

INSTITUTION

STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY

PRINCIPAL INVESTIGATOR

Morse, Gene (Contact)

FUNDING

$1.8M

YEAR

2025

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

The purpose of NIAID Clinical Pharmacology Quality Assurance (CPQA) Program is to provide a comprehensive quality assessment program for clinical pharmacologic laboratories testing samples from subjects enrolled in NIAID-supported clinical studies. The CPQA Program ensures the validity and inter- and intra-laboratory comparability of pharmacological study data by providing laboratories with materials for pharmacology proficiency testing and assay controls, and monitoring proficiency and assay data from each laboratory. The program also develops and implements standards of performance for new pharmacology assays, develops and tests methods relating to the assays, and acquires, tests, stores, and dispenses quality control materials and reagents. Thus, the CPQA Program is critical to the scientific integrity of on-going and future studies concerning the assessment of therapeutic and prevention measures for HIV and other infectious diseases.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESN01laboratoryintegritycomparabilityfutureprovidingclinicalintrastandardsinterpharmacologicassayinfectiousenrolledcontrolensuresniaid

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.